Xi-Long Zheng

Xi-Long Zheng

Dr. Zheng's laboratory mainly focuses on the mechanisms underlying differentiation, proliferation, and aging of vascular smooth muscle cells in vitro and in vivo and their roles in the development of vascular aging and cardiovascular disease. The laboratory has made advances in the field of regulation of smooth muscle differentiation and the cell cycle. Dr. Zheng has published more than 150 peer-reviewed articles since 2001, many of which appear in highly-ranked journals, including Proceedings of the National Academy of Sciences, Arteriosclerosis, Thrombosis, and Vascular Biology, Diabetologia, Journal of Biological Chemistry, Hypertension.

Education

  • M.D. 1981 ‒ 1986 Medicine, Faculty of Medicine, Central South University (Hunan Medical University), Changsha, China.
  • M.Sc. 1986 ‒ 1989 Dept. of Pharmacology, Graduate School, Central South University (Hunan Medical University), Changsha, China.
  • Ph.D. 1993 ‒ 1997, Dept. of Pharmacology & Therapeutics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Postdoctoral Fellow, 1997 ‒ 1998, Dept. of Molecular Pharmacology, the State University of New York at Stony Brook, New York, U.S.A.
  • Postdoctoral Fellow, 1998 ‒ 2001, Dept. of Biochemistry & Molecular Biology, Cumming School of Medicine, University of Calgary, Alberta, Canada.

Scholarship awards

      • Senior Scholar ‒ Alberta Heritage Foundation for Medical Research (AHFMR) Independent Investigator Award, 2008 ‒ 2015.
      • New Investigator Award of the Heart & Stroke Foundation of Canada, 2001 ‒ 2006.
      • Scholarship Award of the Canadian Institutes of Health Research & Hypertension Society of Canada, 2001 ‒ 2004.
      • Fellowship Award of CIHR/PMAC Health Program, the Heart & Stroke Foundation of Canada & AstraZeneca Pharma, 1999 ‒ 2001.
      • Scholarship Award of the Medical Research of Canada/Hypertension Society, 1997 ‒ 1998.

Publications

Click to see the public bibliography

 

Hobbies

Cooking, Running, Biking, etc.